Form 483

EUROSIREL S.P.A Form 483, 2025-09-26

FDA issued a Form 483 to EUROSIREL S.P.A on 2025-09-26 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

EUROSIREL S.P.A · Cusago, Italy · Issued September 26, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Sep 2025
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Shanna N Purdy

26 Sep 2025
21 CFR 211.166(a)

Lack of written stability program

Cited by Shanna N Purdy

26 Sep 2025
21 CFR 211.182

Written records kept in individual logs

Cited by Shanna N Purdy

26 Sep 2025
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Shanna N Purdy

Inspected site

ESEUROSIREL S.P.ACusago, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere